BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/16/2026 11:31:19 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 114176
Country South Korea
Received
2025-09-17 07:09
Peer-Review Started
2025-09-17 07:09
First Decision by Editorial Office Director
2025-11-14 09:13
Return for Revision
2025-11-14 09:13
Revised
2025-11-24 16:49
Publication Fee Transferred
2025-11-26 06:50
Second Decision by Editor
2025-12-15 02:45
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-15 08:05
Articles in Press
2025-12-15 08:05
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-01-09 03:35
Publish the Manuscript Online
2026-01-16 11:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection
Manuscript Source Unsolicited Manuscript
All Author List Jeayeon Park, Jae Yoon Jeong, Soon Sun Kim, Jae Hyun Yoon, Hyuk Soo Eun, Jonggi Choi, Ki Tae Yoon, Young Kul Jung, Soo Young Park, Geum-Youn Gwak, Do Young Kim, Ji Hoon Kim, Jin-Woo Lee, Tae Yeob Kim, Jeong Won Jang and Su Jong Yu
ORCID
Author(s) ORCID Number
Jae Yoon Jeong http://orcid.org/0000-0002-3624-3261
Soon Sun Kim http://orcid.org/0000-0002-6862-1896
Jae Hyun Yoon http://orcid.org/0000-0002-4993-2496
Hyuk Soo Eun http://orcid.org/0000-0003-0485-0072
Ki Tae Yoon http://orcid.org/0000-0002-8580-0239
Young Kul Jung http://orcid.org/0000-0002-6566-1382
Soo Young Park http://orcid.org/0000-0002-4944-4396
Geum-Youn Gwak http://orcid.org/0000-0002-6453-3450
Ji Hoon Kim http://orcid.org/0000-0003-3924-0434
Jin-Woo Lee http://orcid.org/0000-0002-7227-4938
Tae Yeob Kim http://orcid.org/0000-0001-7978-5303
Jeong Won Jang http://orcid.org/0000-0002-0305-5846
Su Jong Yu http://orcid.org/0000-0001-8888-7977
Funding Agency and Grant Number
Funding Agency Grant Number
the Research Supporting Program of the Korean Association for the Study of the Liver and the Korean Liver Foundation KASL2021-02
Corresponding Author Su Jong Yu, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101, DAEHAK-RO JONGNO-GU, Seoul 03080, South Korea. ydoctor2@snu.ac.kr
Key Words Peginterferon; Direct-acting antivirals; Overall survival; Hepatocellular carcinoma; Liver fibrosis
Core Tip Proactive hepatitis C virus (HCV) treatment in human immunodeficiency virus (HIV)/HCV co-infected patients may contribute to improved long-term prognosis. With optimal HIV/HCV treatment regimens, hepatocellular carcinoma occurrence and mortality risks in co-infected patients have become comparable to those in patients with HCV mono-infection.
Publish Date 2026-01-16 11:31
Citation

Park J, Jeong JY, Kim SS, Yoon JH, Eun HS, Choi J, Yoon KT, Jung YK, Park SY, Gwak GY, Kim DY, Kim JH, Lee JW, Kim TY, Jang JW, Yu SJ. Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection. World J Gastroenterol 2026; 32(3): 114176

URL https://www.wjgnet.com/1007-9327/full/v32/i3/114176.htm
DOI https://dx.doi.org/10.3748/wjg.v32.i3.114176
Full Article (PDF) WJG-32-114176-with-cover.pdf
STROBE Statement 114176-STROBE-statement.pdf
Manuscript File 114176_Auto_Edited_062728.docx
Answering Reviewers 114176-answering-reviewers.pdf
Audio Core Tip 114176-audio.m4a
Biostatistics Review Certificate 114176-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 114176-conflict-of-interest-statement.pdf
Copyright License Agreement 114176-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s) 114176-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 114176-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 114176-non-native-speakers.pdf
Supplementary Material 114176-supplementary-material.pdf
Peer-review Report 114176-peer-reviews.pdf
Scientific Misconduct Check 114176-scientific-misconduct-check.png
Scientific Editor Work List 114176-scientific-editor-work-list.pdf
CrossCheck Report 114176-crosscheck-report.pdf